ODDB.org: Open Drug Database

Home - 66216 - 04 - 004

Refixia 3000 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung -

Swissmedic Key	66216004	Registration Holder	Novo Nordisk Pharma AG
Name	Refixia 3000 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	Date of registration	05.09.2017
		Introduction of Sequence	19.12.2023
ATC-Classification	Coagulation Factor Ix (B02BD04)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	06.01.10.	Show package size
Index Therapeuticus (Swissmedic)	06.01.10.	Description
Swissmedic categorie.	B
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	5336.28	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	5516.05
Feedback	FB
GTIN	7680662160040	Medication Code	Biotechnologika
Pharmacode		Disponibility

Composition

Praeparatio cryodesiccata: nonacogum beta pegolum 3000 U.I., natrii chloridum, histidinum, saccharum 10 mg, mannitolum, polysorbatum 80, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, pro vitro corresp. natrium 0.972 mg/ml. Solvens: histidinum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium.

Packungsbestandteile

Label

Solvens

Galenic Form

Lyophilisate and solvent

Excipiens

BAG: Active Agent	Dose
	3000 UI

Inactive agents
Histidine

Label

Praeparatio cryodesiccata:

Galenic Form

Lyophilisate and solvent

Excipiens

Active Agent	Dose
	3000 UI

BAG: Active Agent	Dose
	3000 UI

Inactive agents	Dose

Histidine
Mannitol
Sodium Chloride

Polysorbatum 80
Saccharum	10 mg

Label

Solvens

Galenic Form

Lyophilisate and solvent

Excipiens

BAG: Active Agent	Dose
	3000 UI

Inactive agents

Histidine

Source

Data was imported : 04.07.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH